Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Brands: Reduced immunogenicity of first-trimester human fetal pancreas. (0.12 sec) 

Reduced immunogenicity of first-trimester human fetal pancreas


K Brands, E Colvin, LJ Williams, R Wang, RB Lock, BE … - Diabetes, 2008 - Am Diabetes Assoc
OBJECTIVE—The use of human fetal pancreatic tissue may provide a potential source of transplantable
β-cells as a therapy for type 1 diabetes. Human fetal pancreas has a remarkable capacity to grow
and differentiate in vivo and has been shown to reverse diabetes in rodents. However, it ...
Cited by 7 - Related articles - BL Direct - All 4 versions

Development of new-generation HU-PBMC-NOD/SCID mice to study human islet …


M KING, T Pearson, LD Shultz, J Leif, R … - ANNALS-NEW …, 2007 - interscience.wiley.com
Abstract : The use of "humanized" mice represents an appealing translational model for studies
of the pathogenesis of immune-mediated diseases and for the evaluation of potential
therapeutics. The utility of humanized mice depends on their ability to model the human ...
Cited by 5 - Related articles - BL Direct - All 8 versions

First-trimester human fetal pancreas transplantation for type 1 diabetes treatment: …


G Fousteri, M von Herrath - Diabetes, 2008 - Am Diabetes Assoc
Type 1 diabetes results from immune-mediated destruction of insulin-producing β-cells of the
pancreas. The disease manifests itself symptomatically when the resident β-cells become unable
to maintain normoglycemia. In human insulitis, mainly CD8 lymphocytes and B-cells, but ...
Related articles - BL Direct - All 3 versions

[PDF] An Alternative Approach for Achieving Long-Term Graft Survival?


G Fousteri, M von Herrath - DIABETES, 2008 - Am Diabetes Assoc
T ype 1 diabetes results from immune-mediated destruction of insulin-producing -cells of the
pancreas. The disease manifests itself symptom- atically when the resident -cells become unable
to maintain normoglycemia. In human insulitis, mainly CD8 lymphocytes and B-cells, but ...
Related articles

β cell regeneration


BE Tuch, K Kannangara - Drug Discovery Today: Therapeutic Strategies, 2009 - Elsevier
Replacing the 350 million β cells destroyed in people with type 1 diabetes has traditionally been
sought by transplanting human pancreatic tissue obtained after death. Alternative sources of
exogenous surrogate β cells being examined include stem cells, fetal pancreas and cells ...
Related articles

Fetal intestinal graft is the best source for intestinal transplantation


MF Lopes, AMS Cabrita, JAB Patrício - Pediatric surgery international, 2000 - Springer
Abstract Adult intestinal allografts have demonstrated high immunogenicity in human
transplantation, making the search for new and more favorable grafts an actual problem. Accepting
that fetal and newborn immune systems are relatively immature, their intestines could be ...
Cited by 8 - Related articles - BL Direct - All 3 versions

Development of human fetal pancreas after transplantation into SCID mice


Z Si, BE Tuch, DA Walsh - Cells Tissues Organs, 2000 - content.karger.com
Only a small component of human fetal pancreas consists of cells, and yet this tissue is capable
of normalizing the blood glucose levels of diabetic recipients when transplanted. The time taken
to achieve this goal is several months, during which time the tissue proliferates and ...
Cited by 9 - Related articles - BL Direct - All 4 versions

Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in …


LD Shultz, T Pearson, M KING, L GIASSI, … - ANNALS-NEW …, 2007 - interscience.wiley.com
Abstract : There are many rodent models of autoimmune diabetes that have been used to study
the pathogenesis of human type 1 diabetes (T1D), including the non-obese diabetic (NOD)
mouse, the biobreeding (BB) rat, and the transgenic mouse models. However, mice and ...
Cited by 9 - Related articles - BL Direct - All 7 versions

Stem cells derived from amniotic fluid: new potentials in regenerative medicine


M Cananzi, A Atala, P De Coppi - Reproductive BioMedicine Online, 2009 - ingentaconnect.com
Paolo De Coppi is a Clinical Senior Lecturer and Consultant in Paediatric Surgery at the UCL
Institute of Child Health and Great Ormond Street Hospital, London, UK. His clinical training and
PhD in tissue engineering and cell transplantation (2002) were undertaken at the ...
Cited by 2 - Related articles - All 2 versions

Survey of the Human Pancreatic {beta}-Cell G1/S Proteome Reveals a Potential …

- diabetesjournals.org
N Fiaschi-Taesch, TA Bigatel, B Sicari, KK Takane, F … - Diabetes, 2009 - Am Diabetes Assoc
OBJECTIVES To comprehensively inventory the proteins that control the G1/S cell cycle checkpoint
in the human islet and compare them with those in the murine islet, to determine whether these
might therapeutically enhance human β-cell replication, to determine whether human ...
Cited by 1 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google